- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1326
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neuroimaging Biomarkers for Alzheimer’s Disease ; volume:14 ; number:1 ; day:7 ; month:6 ; year:2019 ; pages:1-14 ; date:12.2019
Molecular neurodegeneration ; 14, Heft 1 (7.6.2019), 1-14, 12.2019
- Creator
-
Márquez, Freddie
Yassa, Michael A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13024-019-0325-5
- URN
-
urn:nbn:de:101:1-2019102123265524975498
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Márquez, Freddie
- Yassa, Michael A.
- SpringerLink (Online service)
Other Objects (12)
Blood biomarkers for Alzheimer’s disease
Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative
Biomarkers in Alzheimer’s disease
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Exploring modulators of tau spreading in Alzheimer’s disease through multi-modal neuroimaging biomarkers
Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort
Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer’s disease
Blood-based molecular biomarkers for Alzheimer’s disease
Knowledge-driven binning approach for rare variant association analysis: application to neuroimaging biomarkers in Alzheimer’s disease
Author Correction: Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer’s disease
Blood‐based biomarkers for Alzheimer's disease
Blood biomarkers for Alzheimer’s disease
Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative
Biomarkers in Alzheimer’s disease
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Exploring modulators of tau spreading in Alzheimer’s disease through multi-modal neuroimaging biomarkers
Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort
Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer’s disease
Blood-based molecular biomarkers for Alzheimer’s disease
Knowledge-driven binning approach for rare variant association analysis: application to neuroimaging biomarkers in Alzheimer’s disease
Author Correction: Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer’s disease
Blood‐based biomarkers for Alzheimer's disease
Blood biomarkers for Alzheimer’s disease
Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative
Biomarkers in Alzheimer’s disease
Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Exploring modulators of tau spreading in Alzheimer’s disease through multi-modal neuroimaging biomarkers
Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer’s Disease Neuroimaging Initiative cohort
Impacts of CR1 genetic variants on cerebrospinal fluid and neuroimaging biomarkers in alzheimer’s disease
Blood-based molecular biomarkers for Alzheimer’s disease
Knowledge-driven binning approach for rare variant association analysis: application to neuroimaging biomarkers in Alzheimer’s disease
Author Correction: Neuroimaging biomarkers and CSF sTREM2 levels in Alzheimer’s disease: a longitudinal study
Topographic patterns of white matter hyperintensities are associated with multimodal neuroimaging biomarkers of Alzheimer’s disease